SCHEMBL15870375

SCHEMBL15870375

O=c1oc2cc(O)ccc2c2oc3cc(O)c(O)cc3c12

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.82
MEN1 O00255 4/20 0.82
KDM4E B2RXH2 4/20 0.82
MAPT P10636 3/20 0.82
RECQL P46063 3/20 0.82
BLM P54132 3/20 0.82
ESR1 P03372 3/20 0.82
ESR2 Q92731 3/20 0.82
GAA P10253 2/20 0.82
HPGD P15428 2/20 0.82
THRB P10828 2/20 0.82
TDP1 Q9NUW8 2/20 0.82
ALDH1A1 P00352 2/20 0.82
MAOA P21397 2/20 0.82
MGAM O43451 1/20 0.82
NR1I2 O75469 1/20 0.82
LMNA P02545 1/20 0.82
GLA P06280 1/20 0.82
POLB P06746 1/20 0.82
CSNK2A2 P19784 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Coumestrol SCHEMBL22012 0.90 ESR2 (1.00) KMT2AMEN1KDM4EMAPTRECQL
Coumestrol SCHEMBL29453366 0.90 ESR2 (1.00) KMT2AMEN1KDM4EMAPTRECQL
SCHEMBL15870374 0.89 ESR2 (0.84) KMT2AMEN1KDM4EMAPTRECQL
SCHEMBL5918258 0.85 MEN1 (0.68) KMT2AMEN1KDM4EMAPTRECQL
SCHEMBL2439156 0.84 KDM4E (1.00) KMT2AMEN1KDM4EMAPTRECQL
SCHEMBL30004934 0.83 KDM4E (0.85) KMT2AMEN1KDM4EMAPTRECQL
SCHEMBL29603115 0.83 ESR2 (0.74) KMT2AMEN1KDM4EMAPTRECQL
SCHEMBL15870371 0.83 KDM4E (0.85) KMT2AMEN1KDM4EMAPTRECQL
SCHEMBL234819 0.83 KDM4E (0.85) KMT2AMEN1KDM4EMAPTRECQL
SCHEMBL30006760 0.83 KDM4E (0.85) KMT2AMEN1KDM4EMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150336977-A1 Coumestan, Coumestrol, Coumestan Derivatives and Processes of Making the Same and Uses of Same BG NEGEV TECHNOLOGIES & APPLIC LTD (IL) 2015-11-26 US disclosed
US-20150336977-A1 Coumestan, Coumestrol, Coumestan Derivatives and Processes of Making the Same and Uses of Same BG NEGEV TECHNOLOGIES & APPLIC LTD (IL) 2015-11-26 US disclosed
WO-2014106848-A1 COUMESTAN, COUMESTROL, COUMESTAN DERIVATIVES AND PROCESSES OF MAKING THE SAME AND USES OF SAME B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. (IL) 2014-07-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336977-A1 Coumestan, Coumestrol, Coumestan Derivatives and Processes of Making the Same and Uses of Same CYP19A1, ESR1, GPER1 KMT2A 1357/4885MEN1 954/4885KDM4E 880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.